An Open-Label, Multi-Centre, Phase I/II Study to Investigate the Safety, Tolerability, and Preliminary Efficacy of CN1 in combination with CN401 in adult patients with relapsed/refractory lymphoid malignancies

Project: Research

Project Details

StatusActive
Effective start/end date8/07/217/07/26

Keywords

  • phase 1 and 2 study
  • treatment safety
  • treatment efficacy
  • lymphoma